CHI Advisors as of Dec. 31, 2020
Portfolio Holdings for CHI Advisors
CHI Advisors holds 21 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Repare Therapeutics Ord (RPTX) | 24.4 | $87M | 2.5M | 34.30 | |
| Oncorus | 15.3 | $54M | 1.7M | 32.33 | |
| Pliant Therapeutics (PLRX) | 15.0 | $54M | 2.4M | 22.72 | |
| Larimar Therapeutics (LRMR) | 9.1 | $32M | 1.5M | 21.41 | |
| Keros Therapeutics (KROS) | 8.6 | $31M | 434k | 70.54 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 7.0 | $25M | 1.4M | 18.26 | |
| Inozyme Pharma (INZY) | 5.8 | $21M | 995k | 20.64 | |
| Akouos | 4.9 | $17M | 871k | 19.83 | |
| Orchard Therapeutics Ads | 3.6 | $13M | 2.9M | 4.32 | |
| Precision Biosciences Ord | 2.0 | $7.2M | 862k | 8.34 | |
| American Well Corp Cl A | 1.8 | $6.3M | 248k | 25.33 | |
| Ovid Therapeutics (OVID) | 0.5 | $1.9M | 827k | 2.31 | |
| Global Blood Therapeutics In | 0.5 | $1.9M | 43k | 43.29 | |
| Corvus Pharmaceuticals (CRVS) | 0.5 | $1.7M | 491k | 3.56 | |
| G1 Therapeutics | 0.3 | $1.1M | 62k | 17.98 | |
| Kezar Life Sciences | 0.2 | $705k | 135k | 5.22 | |
| Adverum Biotechnologies | 0.2 | $642k | 59k | 10.84 | |
| Blueprint Medicines (BPMC) | 0.2 | $617k | 5.5k | 112.18 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $415k | 3.0k | 138.33 | |
| Bluebird Bio | 0.1 | $346k | 8.0k | 43.25 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 0.0 | $54k | 10k | 5.40 |
